logo
  Join        Login             Stock Quote

AmerisourceBergen Announces Departure of Chief Financial Officer Michael DiCandilo; Tim Guttman to Serve as Acting CFO

Monday, February 13, 2012 7:29 AM


Company Reaffirms Fiscal Year 2012 EPS Guidance Range of $2.74 to $2.84

AmerisourceBergen Corporation (NYSE: ABC) today announced that Michael D. DiCandilo, the Company's Executive Vice President and Chief Financial Officer, has left the Company to pursue other interests, effective immediately.

"Mike departs the Company with an impeccable record of service over his 21 years, including the past ten as our Chief Financial Officer," said Steven H. Collis, President and Chief Executive Officer of AmerisourceBergen. "His tremendous contributions to the success of AmerisourceBergen through his fiscal leadership and business stewardship are greatly appreciated, and we wish him all the best in his future endeavors."

Also effective immediately, Tim G. Guttman, the Company's Vice President and Corporate Controller since 2002, will serve as acting CFO and will assume responsibility for the Company's core financial functions on an interim basis. Guttman was previously Vice President, Finance of Syncor International, and held financial planning and financial services managerial positions at Disney Consumer Products, Pizza Hut, Inc. and PepsiCo, Inc.. Guttman started his career as a certified public accountant with accounting firm Deloitte & Touche.

AmerisourceBergen has engaged an executive search firm to manage the recruitment of a new Chief Financial Officer.

In addition, the Company said that it continues to expect diluted earnings per share in fiscal year 2012 to be in the range of $2.74 to $2.84. Also unchanged are the assumptions supporting the expected diluted earnings per share range for fiscal year 2012, including: flat to modest revenue growth; operating margin growth in the high single-digit to low double-digit basis points range; and free cash flow in the range of $700 million to $800 million, which includes capital expenditures in the $150 million range. Subject to market conditions, we continue to expect to spend approximately $400 million to repurchase our common shares in fiscal year 2012.

About AmerisourceBergen

AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes.


Advertisement
Advertisement



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.